Lidocaine kills cancer cells by activating bitter taste receptor, preclinical study shows
Graphical Summary. Credit score: Cell Stories (2023). DOI: 10.1016/j.celrep.2023.113437 Lidocaine—typically used as a numbing agent for outpatient medical procedures—prompts sure ...